TriangleNCT01261247 · OUTCOME
Median Overall Survival Time
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- MEDIAN
- Unit
- months
- Interval / dispersion
- 95% Confidence Interval
- Time frame
- Every 6 months for up to 2 years
What was measured
The median overall survival time is defined as the time from registration to death due to any cause. The distribution of survival time will be estimated using the method of Kaplan-Meier.
Groups in this outcome
Arm I (LBH589)
Patients receive oral 40 mg panobinostat 3 times weekly. Treatment repeats every 28 days for up to 12 courses in the absence of disease progression or unacceptable toxicity.
| Group | Source count |
|---|---|
| Arm I (LBH589) | 39 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Arm I (LBH589) | 14.9 | Not reported | 8.8 | 46.4 | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- 8.8
- upper Limit
- 46.4
- value
- 14.9
- denoms
- counts
- group Id
- OG000
- value
- 39
- units
- Participants
- description
- The median overall survival time is defined as the time from registration to death due to any cause. The distribution of survival time will be estimated using the method of Kaplan-Meier.
- dispersion Type
- 95% Confidence Interval
- groups
- description
- Patients receive oral 40 mg panobinostat 3 times weekly. Treatment repeats every 28 days for up to 12 courses in the absence of disease progression or unacceptable toxicity.
- id
- OG000
- title
- Arm I (LBH589)
- param Type
- MEDIAN
- reporting Status
- POSTED
- time Frame
- Every 6 months for up to 2 years
- title
- Median Overall Survival Time
- type
- SECONDARY
- unit Of Measure
- months
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice